GPC3 and neoplasm: Similarly, another group verified that pretreatment the tumor by a recombinant adeno-associated virus carrying the CCL19 gene (AAV-CCL19) could increase the infiltration of GPC3 CAR-T to tumor tissue and significantly prolonged the survival time of mice (114).